Literature DB >> 620267

Metacarpal morphometry in adults with osteogenesis imperfecta.

C R Paterson.   

Abstract

Osteogenesis imperfecta is often regarded as a form of osteoporosis. In many cases, particularly those in whom the first fracture occurs outside the neonatal period, bones that have not been fractured may appear radiologically normal. In a group of 24 adults with osteogenesis imperfecta the thickness of the metacarpal cortex was normal but their bones were often slender. Osteoporosis is probably not an inevitable feature of such cases, and some of the radiological abnormalities reported may be the results of previous fractures and their treatment.

Entities:  

Mesh:

Year:  1978        PMID: 620267      PMCID: PMC1602549          DOI: 10.1136/bmj.1.6107.213

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  1 in total

1.  Altered relation of two collagen types in osteogenesis imperfecta.

Authors:  B Sykes; M J Francis; R Smith
Journal:  N Engl J Med       Date:  1977-05-26       Impact factor: 91.245

  1 in total
  5 in total

1.  Osteogenesis imperfecta and other bone disorders in the differential diagnosis of unexplained fractures.

Authors:  C R Paterson
Journal:  J R Soc Med       Date:  1990-02       Impact factor: 5.344

2.  Osteogenesis imperfecta in the differential diagnosis of child abuse.

Authors:  C R Paterson; S J McAllion
Journal:  BMJ       Date:  1989-12-09

3.  Bone density in osteogenesis imperfecta may well be normal.

Authors:  C R Paterson; P A Mole
Journal:  Postgrad Med J       Date:  1994-02       Impact factor: 2.401

4.  Vertebral bone mineral content in osteogenesis imperfecta.

Authors:  D Kurtz; K Morrish; J Shapiro
Journal:  Calcif Tissue Int       Date:  1985-01       Impact factor: 4.333

5.  Assessment of longitudinal bone growth in osteogenesis imperfecta using metacarpophalangeal pattern profiles.

Authors:  Damian Rauch; Marie-Eve Robinson; Cristian Seiltgens; V Reid Sutton; Brendan Lee; Francis Glorieux; Frank Rauch
Journal:  Bone       Date:  2020-07-27       Impact factor: 4.398

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.